Ontology highlight
ABSTRACT:
SUBMITTER: Choi JC
PROVIDER: S-EPMC5066428 | biostudies-other | 2016 Sep
REPOSITORIES: biostudies-other
Choi Jay Chol JC Lee Ji Sung JS Park Tai Hwan TH Cho Yong-Jin YJ Park Jong-Moo JM Kang Kyusik K Lee Kyung Bok KB Lee Soo Joo SJ Kim Jae Guk JG Lee Jun J Park Man-Seok MS Choi Kang-Ho KH Kim Joon-Tae JT Yu Kyung-Ho KH Lee Byung-Chul BC Oh Mi-Sun MS Cha Jae-Kwan JK Kim Dae-Hyun DH Nah Hyun-Wook HW Kim Dong-Eog DE Ryu Wi-Sun WS Kim Beom Joon BJ Bae Hee-Joon HJ Kim Wook-Joo WJ Shin Dong-Ick DI Yeo Min-Ju MJ Sohn Sung Il SI Hong Jeong-Ho JH Lee Juneyoung J Hong Keun-Sik KS
Journal of stroke 20160930 3
<h4>Background and purpose</h4>About 30%-40% of stroke patients are taking antiplatelet at the time of their strokes, which might increase the risk of symptomatic intracranial hemorrhage (SICH) with intravenous tissue plasminogen activator (IV-TPA) therapy. We aimed to assess the effect of prestroke antiplatelet on the SICH risk and functional outcome in Koreans treated with IV-TPA.<h4>Methods</h4>From a prospective stroke registry, we identified patients treated with IV-TPA between October 2009 ...[more]